<div id="readability-page-1">A 4% increase in organic revenue was recorded, driven by growth in all operating segments. Operating income saw a notable 10% rise, leading to a margin expansion to 10.1%. However, reported operating income declined by 14% and reported net income also decreased due to one-time costs linked to the FME25+ transformation program.</div>

<p>A 4% increase in organic revenue was recorded, driven by growth in all operating segments. Operating income saw a notable 10% rise, leading to a margin expansion to 10.1%. However, reported operating income declined by 14% and reported net income also decreased due to one-time costs linked to the FME25+ transformation program.</p>

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed